Prostap SR (Leuprorelin Acetate) DCS 3.75mg Syringe POM x1
Prostap® SR DCS
Product Description
Contains active ingredient leuprorelin acetate
• Prostap® SR is a synthetic hormone which can be used to reduce the levels of testosterone and estrogen circulating in the body.
• It is used to treat prostate cancer in men and endometriosis and uterine fibroids in women. It can also be used to reduce the thickness of the lining (endometrium) of the womb (uterus) in preparation for surgery.
Features
Product information
Prostap® SR DCS 3.75mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
• Powder and solvent for suspension for injection in pre-filled syringe
• Powder: A sterile, lyophilised, white, odourless powder
• Solvent: A clear, odourless, slightly viscous, sterile solvent
• Prostap® 3 DCS also available
Storage
• Once reconstituted with sterile solvent, the suspension should be administered immediately
• Do not store above 25°C
• Do not refrigerate or freeze
• Store in the original container in order to protect from light
Technical information
Pack measurements: 33mm x 186mm x 89mm
Weight: 51.9g
Patient Information Leaflet
https://www.medicines.org.uk/emc/files/pil.4650.pdf
Brand | Takeda |
Presentation | Syringe |
Pack size | 1 |
Brand | Takeda |
Presentation | Syringe |
Presentation | Syringe |